ArticleAngewandte Chemie (International ed. in English)2025
Bicyclic Selenenyl Sulfides with Tuned Bioreductive Step Rates Reveal Constraints for Probes Targeting Thioredoxin Reductase.
Article in Angewandte Chemie (International ed. in English), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Bicyclic Selenenyl Sulfides with Tuned Bioreductive Step Rates Reveal Constraints for Probes Targeting Thioredoxin Reductase.Angewandte Chemie (International ed. in English) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The reductive activation of dichalcogenide probes by thiol-type oxidoreductases proceeds through a cascade of consecutive, partly reversible steps. Stereocontrol elements can modulate the reaction rates of these steps to reach substrate-controlled kinetic selectivity for reductase chemotypes in live cells. We now deploy regio-, diastereo-, template-, and pH-control elements to shape the reactivity of unprecedented bicyclic selenenyl sulfides (SeSP), arriving at probes that selectively target the mammalian selenoenzyme thioredoxin reductase TrxR1. We accessed these densely functionalised cis- or trans-fused 1,2-thiaselenanes on gram scale over 5 steps by using a regioselective key step that elaborates an unusual, differentially protected 2,2'-bis-aziridine intermediate through sequential one-pot chalcogen introduction and selenenyl sulfide formation. By profiling a set of regio- and diastereoisomeric bicycles for their partly or fully reversible reactivity during reductive activation, we show how effects that slow their reduction steps (addition then resolution) can compensate by vastly accelerating subsequent activation (cyclisation) speeds, such that cellular processing is effective and TrxR-selective. More broadly, this study shows how multistep cascade probes can leverage conformational effects and internal noncovalent interactions to differentiate step kinetics along their on-target versus off-target reaction pathways, thus achieving reaction-based target selectivity in complex biological settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.